10-79946525-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_003019.5(SFTPD):āc.135T>Cā(p.Ser45Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0619 in 1,613,760 control chromosomes in the GnomAD database, including 3,521 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.048 ( 239 hom., cov: 33)
Exomes š: 0.063 ( 3282 hom. )
Consequence
SFTPD
NM_003019.5 synonymous
NM_003019.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.42
Genes affected
SFTPD (HGNC:10803): (surfactant protein D) The protein encoded by this gene is part of the innate immune response, protecting the lungs against inhaled microorganisms and chemicals. The encoded protein may also be involved in surfactant metabolism. [provided by RefSeq, Jul 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 10-79946525-A-G is Benign according to our data. Variant chr10-79946525-A-G is described in ClinVar as [Benign]. Clinvar id is 165218.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.42 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0732 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SFTPD | NM_003019.5 | c.135T>C | p.Ser45Ser | synonymous_variant | 2/8 | ENST00000372292.8 | NP_003010.4 | |
SFTPD | XM_011540087.2 | c.135T>C | p.Ser45Ser | synonymous_variant | 2/8 | XP_011538389.1 | ||
SFTPD | XM_011540088.3 | c.135T>C | p.Ser45Ser | synonymous_variant | 2/7 | XP_011538390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFTPD | ENST00000372292.8 | c.135T>C | p.Ser45Ser | synonymous_variant | 2/8 | 1 | NM_003019.5 | ENSP00000361366.3 | ||
SFTPD | ENST00000444384.3 | c.174T>C | p.Ser58Ser | synonymous_variant | 2/6 | 3 | ENSP00000394325.1 | |||
ENSG00000283913 | ENST00000421889.1 | n.334-3503A>G | intron_variant | 3 | ||||||
ENSG00000283913 | ENST00000453174.7 | n.962-3503A>G | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0479 AC: 7278AN: 151892Hom.: 239 Cov.: 33
GnomAD3 genomes
AF:
AC:
7278
AN:
151892
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0462 AC: 11604AN: 251372Hom.: 381 AF XY: 0.0458 AC XY: 6222AN XY: 135872
GnomAD3 exomes
AF:
AC:
11604
AN:
251372
Hom.:
AF XY:
AC XY:
6222
AN XY:
135872
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0634 AC: 92658AN: 1461750Hom.: 3282 Cov.: 32 AF XY: 0.0622 AC XY: 45200AN XY: 727186
GnomAD4 exome
AF:
AC:
92658
AN:
1461750
Hom.:
Cov.:
32
AF XY:
AC XY:
45200
AN XY:
727186
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0479 AC: 7274AN: 152010Hom.: 239 Cov.: 33 AF XY: 0.0445 AC XY: 3308AN XY: 74316
GnomAD4 genome
AF:
AC:
7274
AN:
152010
Hom.:
Cov.:
33
AF XY:
AC XY:
3308
AN XY:
74316
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
32
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | Ser45Ser in exon 2 of SFTPD: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. It has been identified in 6.8% (589/8600) of Eu ropean American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs6413520). - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at